4,0
9. Juli 2023
Ehemaliger Mitarbeiter, mehr als 1 Jahr
South San Francisco, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
- Truly among the most state-of-the-art, ambitious cancer treatment innovation (fully personalized [genomically] cell therapy) - At its peak had an incredible team of hard-working, passionate, brilliant scientists who achieved successful R&D + manufacturing + clinical (etc.) progress milestones at an almost unbelievable clip
Kontras
- Too many poor managers - Too many people suddenly hired too quickly